Design of novel assays based on the newly found role of dystroglycan and alpha-dystroglycan proteolysis in tumor cell growth
Patent
·
OSTI ID:1175602
The invention provides method for assessing tumorigenicity of mammalian cells by assaying the proteolytic fragments of 120-130 kD alpha-dystroglycan in medium surrounding mammalian cells.
- Research Organization:
- Univ. of California, Oakland, CA (United States); Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States)
- Sponsoring Organization:
- USDOE
- DOE Contract Number:
- AC03-76SF0098
- Assignee:
- The Regents of the University of California (Oakland, CA)
- Patent Number(s):
- 6,982,151
- Application Number:
- 09/652,493
- OSTI ID:
- 1175602
- Country of Publication:
- United States
- Language:
- English
Similar Records
Drug screens based on the newly found role of dystroglycan proteolysis and restoration of dystroglycan function thereof
Defective chromatin recruitment and retention of NHEJ core components in human tumor cells expressing a Cyclin E fragment
Effects of cell growth rate on the structure and activity of DNA polymerase alpha
Patent
·
Tue Feb 23 00:00:00 EST 2010
·
OSTI ID:1175602
Defective chromatin recruitment and retention of NHEJ core components in human tumor cells expressing a Cyclin E fragment
Journal Article
·
Mon Sep 09 00:00:00 EDT 2013
· Nucleic Acids Research
·
OSTI ID:1175602
+3 more
Effects of cell growth rate on the structure and activity of DNA polymerase alpha
Conference
·
Fri May 01 00:00:00 EDT 1987
· Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States)
·
OSTI ID:1175602
+1 more